Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Osteoarthritis Therapeutics Market Growth Potential: How Will Market Size Change Through 2030?
The market for osteoarthritis therapeutics has experienced robust expansion historically and is projected to continue this trend, escalating from $8.87 billion in 2025 to $9.63 billion in 2026, reflecting a compound annual growth rate of 8.6%. Key factors contributing to this growth during the past period include the increasing incidence of osteoarthritis, an aging demographic worldwide, the extensive utilization of non-steroidal anti-inflammatory drugs and painkillers, the broadening of orthopedic healthcare provisions, and the accessibility of established pain management treatments.
The market for osteoarthritis therapeutics is poised for considerable expansion in the upcoming years, projecting a valuation of $13.21 billion by 2030, fueled by a compound annual growth rate of 8.2%. This anticipated growth stems from advancements in disease-modifying osteoarthritis drugs (DMOADs), a surge in demand for less invasive treatment options, the burgeoning field of biologic and cell-based therapies, a heightened focus on tailored patient care for osteoarthritis, and increased funding allocated to joint disease research. Key market dynamics expected during this period involve a greater acceptance of DMOADs, an elevated utilization of regenerative medicine techniques, a stronger emphasis on pain management strategies that avoid opioids, a broader availability of injectable and intra-articular treatments, and an intensified focus on intervening in the disease’s early stages.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19634&type=smp
Osteoarthritis Therapeutics Market Growth Factors Supporting Long-Term Expansion
The escalating incidence of sports-related injuries is anticipated to be a significant catalyst for the expansion of the osteoarthritis therapeutics market. Injuries sustained during athletic pursuits, encompassing a spectrum from minor sprains to severe trauma affecting diverse anatomical regions, are becoming more prevalent due to increased engagement in sports and heightened levels of competition and exertion. Osteoarthritis treatments play a crucial role in addressing these injuries by alleviating pain and inflammation, as well as enhancing joint mobility for athletes experiencing joint deterioration. Illustratively, data from the Australian Institute of Health and Welfare, a governmental body in Australia, indicated that for the 2023–24 period, approximately 62,100 sports injuries in Australia necessitated hospital admission. Of these, males constituted a substantial 70% (equivalent to 43,800 admissions), whereas females represented close to 30% (18,300 admissions). Consequently, the increasing rates of sports injuries are directly contributing to the market’s growth for osteoarthritis therapeutics.
Osteoarthritis Therapeutics Market Segment Landscape: Which Areas Lead Market Development?
The osteoarthritis therapeutics market covered in this report is segmented –
1) By Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids
2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses
Subsegments:
1) By Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products
2) By Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors
3) By Analgesics: Non-Opioid Analgesics, Topical Analgesics
4) By Corticosteroids: Injectable Corticosteroids, Intra-Articular Corticosteroids
Osteoarthritis Therapeutics Market Industry Trends Shaping Future Revenue Growth
Companies dominating the osteoarthritis therapeutics sector are prioritizing the creation of groundbreaking treatments, including novel approaches for regenerating damaged tissues affected by osteoarthritis, a condition involving the repair or replacement of worn-out cartilage and joint tissues to restore function and ease discomfort. For example, a significant development occurred in May 2023 when the U.S. government entity, the Advanced Research Projects Agency for Health (ARPA-H), introduced the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) initiative. This groundbreaking program is dedicated to advancing state-of-the-art injectable treatments designed to encourage cartilage regrowth by harnessing biological mechanisms akin to those present during early development, employing a cooperative strategy involving diverse research groups and sophisticated evaluation methods like “joint-on-a-chip” technology to effectively replicate joint conditions and engineer regenerative therapies targeting the root causes of osteoarthritis.
Osteoarthritis Therapeutics Market Industry Leaders And Market Competition
Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Galapagos NV, Regeneron Pharmaceuticals Inc., Samumed LLC, Kolon Life Science Inc., Horizon Therapeutics plc
Access The Complete Osteoarthritis Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report
Osteoarthritis Therapeutics Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the osteoarthritis therapeutics market in 2025. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
